Free Trial

Forte Biosciences 8/14/2024 Earnings Report

Forte Biosciences logo
$15.89 -0.07 (-0.44%)
As of 01/31/2025 04:00 PM Eastern

Forte Biosciences EPS Results

Actual EPS
-$0.27
Consensus EPS
-$0.16
Beat/Miss
Missed by -$0.11
One Year Ago EPS
N/A

Forte Biosciences Revenue Results

Actual Revenue
N/A
Expected Revenue
N/A
Beat/Miss
N/A
YoY Revenue Growth
N/A

Forte Biosciences Announcement Details

Quarter
Time
After Market Closes

Conference Call Resources

Forte Biosciences Earnings Headlines

Forte Biosciences (NASDAQ:FBRX) Coverage Initiated at TD Cowen
Buy NVDA Now?
After weeks of volatility, did President Trump just turn Nvidia (NVDA) into a raging BUY? The beloved chipmaker has struggled this year, facing increased competition and regulatory pressure.
Forte Biosciences initiated with a Buy at TD Cowen
See More Forte Biosciences Headlines
Get Earnings Announcements in your inbox

Want to stay updated on the latest earnings announcements and upcoming reports for companies like Forte Biosciences? Sign up for Earnings360's daily newsletter to receive timely earnings updates on Forte Biosciences and other key companies, straight to your email.

About Forte Biosciences

Forte Biosciences (NASDAQ:FBRX) operates as a biopharmaceutical company in the United States. The company is developing FB-102 program that addresses various autoimmune diseases, such as graft-versus-host disease, and vitiligo and alopecia areata. Forte Biosciences, Inc. is headquartered in Dallas, Texas.

View Forte Biosciences Profile

More Earnings Resources from MarketBeat